GlassScriptPhysician profile
Dennis Patrick Deruelle
NPI 1265429203
$263,214.11
in general payments reported to CMS, 2019-2025
9 companies · $3,352 in 2025
The $3,352 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $600 · 2020: $12K · 2021: $30K · 2022: $82K · 2023: $125K · 2024: $10K · 2025: $3,352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $105K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $23K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,080 · Travel and Lodging: $4,221 · Food and Beverage: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $105,167.87 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $22,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,080.00 |
| Travel and Lodging | $4,221.02 |
| Food and Beverage | $1,050.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $219,228.44 | 2020-2025 | Ultomiris |
| Cepheid | $34,304.89 | 2019-2025 | Genexpert, Genexpert Infinity-48s System |
| Ferring Pharmaceuticals INC. | $7,129.94 | 2020-2022 | |
| Gilead Sciences, INC. | $1,363.63 | 2023-2025 | Veklury |
| Baudax Bio INC. | $1,105.00 | 2021 | |
| Allergan, INC. | $25.23 | 2022 | |
| Janssen Pharmaceuticals, INC | $21.37 | 2024 | Xarelto |
| Abbvie INC. | $20.68 | 2023 | |
| Abbott Laboratories | $14.93 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Deruelle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.